Could proton pump inhibitors cause cancer?

Area of Science:

• Pharmacology
• Gastroenterology
• Clinical Medicine

Background:

• Proton pump inhibitors (PPIs) are widely prescribed for acid-related gastrointestinal disorders.
• Concerns exist regarding the potential long-term adverse effects associated with prolonged PPI use.
• This work addresses a review on the perils and pitfalls of long-term PPI therapy.

Discussion:

• The review critically examines the evidence linking PPIs to various adverse events.
• Potential risks include bone fractures, Clostridium difficile infections, and vitamin B12 deficiency.
• The authors emphasize the importance of judicious PPI prescribing and de-escalation strategies.

Key Insights:

• Long-term PPI use may increase the risk of bone mineral density loss and fractures.
• Increased susceptibility to enteric infections, such as Clostridium difficile, is a noted concern.
• Potential for drug interactions and nutrient malabsorption warrants attention.

Outlook:

• Further research is needed to fully elucidate the mechanisms and clinical significance of PPI-associated risks.
• Clinical guidelines should emphasize appropriate PPI indication, duration, and regular reassessment.
• Promoting the lowest effective PPI dose and exploring alternative therapies are crucial for patient safety.